The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The placebo control is key, and it was at least statistically better than placebo.
You’re right that it’s hard to tell if it is more or less effective than hydrocodone+acetaminophen but it’s good news either way because it can potentially reduce the use of opioids and be another option.
The placebo control is key, and it was at least statistically better than placebo.
You’re right that it’s hard to tell if it is more or less effective than hydrocodone+acetaminophen but it’s good news either way because it can potentially reduce the use of opioids and be another option.